Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1507650

Cover Image

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1507650

Clinical Nutrition Market - Global Outlook & Forecast 2024-2029

PUBLISHED:
PAGES: 464 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4200
PDF (5 User License)
USD 4999
PDF (Corporate User License)
USD 5999

Add to Cart

The global clinical nutrition market is expected to grow at a CAGR of 7.35% from 2023 to 2029.

MARKET TRENDS & DRIVERS

Rise of Targeted & Personalized Nutrition

Personalization nutrition is a rapidly growing field in the clinical nutrition market that includes science-based assessments to deliver individuals with targeted nutritional products or advice. Medical professionals and patients are moving away from a one-size-fits-all approach to value their nutritional goals. Personalized clinical nutrition or precision clinical nutrition, which utilizes nutritional products, lifestyle, and individual biomarkers to craft healthy nutritional suggestions more relevant to the individual, continues to gain popularity. Personalization and a targeted solution came up with highly specific and fully developed formulas that fulfill the needs of individual patients/people for nutritional support. Innovation in targeted and personalized solutions has grown and evolved rapidly in recent years, increasing consumer demand for food systems to support their health and well-being.

Growing Need for Clinical Nutrition in Geriatric Population

Worldwide, the rapidly growing geriatric population has witnessed the significant impact of severe health conditions. The growing geriatric population is a major contributor to clinical nutrition market growth. Many regions are experiencing growth in their elderly population, which is highly susceptible to chronic diseases that demand clinical nutrition products during hospitalization and home care. Furthermore, the significant prevalence of severe health conditions and the demand for healthcare that often comes with aging means medical nutrition has a huge role in meeting the nutrient requirements of seniors. Medical nutrition solutions are used in and outside health settings to support surgery recovery, loss of bone and muscle, nutrient malabsorption common with aging, and many other conditions. In the APAC region, the growing aging population and expanding health facilities indicate a strong future for the clinical nutrition industry.

Growing R&D for New Compounds and Elements in Clinical Nutrition

The clinical nutrition field is continuously evolving new compounds and elements. The constant development of new compounds and elements delivers lucrative opportunities for patient care and the evolution of new clinical nutrition products. Some new and developed compounds have become more popular in recent years due to advances in supplementation, new formulations, and research in the field. Trace elements (TE) used in parenteral nutrition products are becoming popular due to advances and increasing research and development activities. Previously, multi-trace elements were poorly appreciated and not subjected to thorough oversight by the US Food & Drug Administration (FDA). After ASPEN issued the dosage for parenteral nutrition, trace elements witnessed various developments. Now, trace elements are becoming an essential part of medical nutrition. Further, one of the leading companies in the clinical nutrition industry stated that trends underway in medical nutrition include applying some specific amino acids to support patients with malnutrition and muscle loss. For example, new science-based applications are also showing up, such as Nestle's post-surgery oral impact powder, which includes Omega-3s, nucleotides, and arginine (amino acid) for immune support.

SEGMENTATION INSIGHTS

INSIGHTS BY ROUTE OF ADMINISTRATION

The global clinical nutrition market by route of administration is segmented into oral, enteral, and parenteral. In 2023, the oral segment accounted for more than 60% of the market share and dominated the other segments. The oral route of administration is easy and reliable, giving more clinical nutrition product deliveries and contributing to a significant market share. Oral nutrition support products offer additional nutrients, including energy and protein, for people and patients who cannot achieve nutritional requirements through food alone. Further, vendors' continuous development of oral clinical nutrition products, such as product form, is accelerating segmental growth.

Segmentation by Route of Administration

  • Oral
  • Enteral
  • Parenteral

INSIGHTS BY PRODUCT FORM

The powder products form segment accounted for the most substantial share of the global clinical nutrition market in 2023. Powder-form products are most reliable in clinical nutrition deliveries across all age groups and populations. The powder form is observing a high intake among children and adults as it reduces the complications related to swallowing. Most standard clinical nutrition products are powder-based as they satisfy micronutrient and macronutrient requirements. Powder forms are also preferred as they have extended shelf life, offer superior stability during processing, and are easy to handle, transport, and store. Such factors make powder from clinical nutrition more popular.

Segmentation by Product Form

  • Powder
  • Liquid
  • Semi-Solid

INSIGHTS BY AGE GROUP

The global clinical nutrition market by age group is segmented into child & teenager, infant & toddler, adult, and geriatric. In 2023, the child and teenager segment accounted for the largest segmental share. The higher burden of malnutrition and nutritional deficiency among children and the teenage population accelerates the higher segmental growth. Globally, over 100 million children under age 1 to 5 are undernourished, which offers a broad targeted patient population for market growth. On the other hand, the infant & toddler segment accounts for a second higher market share; the rapidly increasing burden of the preterm birth rate worldwide demands clinical nutrition supplies among infants and toddlers.

Segmentation by Age Group

  • Child & Teenager
  • Infant & Toddler
  • Adult
  • Geriatric

INSIGHTS BY APPLICATION

The global clinical nutrition market by application is segmented into malnutrition, metabolic disease, gastrointestinal diseases, cancer, and others. The malnutrition segment dominated the segmental share and is projected to grow at a CAGR of over 6% during the forecast period. The rising prevalence of malnutrition, metabolic disorders, GI disorders, cancer, and others accelerates the disease-associated malnutrition prevalence and drives demand for clinical nutrition support from health settings. Also, factors associated with hospitalized patients, such as age, comorbidities, and intensity of care, increase the prevalence of hospitalized malnutrition. Globally, it represents a heavy healthcare burden. Thus, advances in clinical nutrition achieved significant space for hospitalized malnutrition and fueled market growth. Furthermore, during the forecast period, the cancer application segment is expected to grow with a higher CAGR in the clinical nutrition industry.

Segmentation by Application

  • Malnutrition
  • Metabolic Disease
  • Gastrointestinal Diseases
  • Cancer
  • Others

INSIGHTS BY DISTRIBUTION CHANNELS

The institutional sales distribution channels hold the most significant share of the global clinical nutrition market in 2023. The significant deliveries of clinical nutrition solutions directly by the organization, such as institutional sales channels, significantly accelerated segmental growth. Institutional sales channels are operated with/by vendors, eliminating the third-party seller's involvement and reducing the extra cost burden of consumers. Institutional sales channels are responsible for covering and handling all major clients and associated marketing and sales activities, as well as directly handling healthcare settings for clinical nutritional products.

Segmentation by Distributional Channels

  • Institutional Sale Channels
  • Pharmacies & Drug Stores
  • Supermarkets & Hypermarkets
  • Online Sales Channels
  • Specialty Stores
  • Other Distribution Channels

INSIGHTS BY END-USERS

The global clinical nutrition market by end-users is segmented into hospitals, individuals, home care, and long-term care centers. The hospital's segment accounted for the largest global market share in 2023. The high hospitalization rate and hospital-associated malnutrition are the major factors that drive the high demand for clinical nutrition solutions in hospitals and fuel segmental growth. The shift of healthcare delivery from hospitals to homecare and individual care approaches is expected to drive the other segmental growth. Homecare has been a rapidly growing segment in developed markets in recent years. The availability and support of home clinical nutrition deliveries are expected to propel significant segmental growth in the future.

Segmentation by End-users

  • Hospitals
  • Individuals
  • Homecare
  • Long-term Care Centers

GEOGRAPHICAL ANALYSIS

APAC holds the largest global clinical nutrition market share, accounting for a global revenue share of over 48% in 2023. The increasing rate of preterm birth rate, the significant burden of malnutrition among children, teenagers, and adults, as well as the geriatric population, are significantly driving the demand for clinical nutrition products in APAC countries. Further, in APAC, the initiatives, support, and healthcare programs to improve the regional health index are propelling the market growth in the region. Conversely, North America is the second leading destination for the clinical nutrition market. The increasing geriatric population in the region and high demand for healthcare services across the region drive the hospitalization rate, which leads to malnutrition and the highly targeted population, such as chronically ill and hospitalized patients, thereby driving the high demand for clinical nutrition. Also, the majority of clinical nutrition industry players are present in the U.S., and the higher expenditure on healthcare and awareness about nutritional products are some of the leading factors that boost the market growth in the region.

Segmentation by Geography

  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Poland
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • Egypt

VENDOR LANDSCAPE

The global clinical nutrition market is highly competitive and has a broad range of key competitors' presence from domestic and international markets. Some emerging and new market players create higher competition. Major market players followed mergers and acquisitions, collaborative actions, product launches, market expansion, product promotions, and programs that positively influenced the competitive rivalry across the global market landscape. On the other hand, emerging market players and new start-ups are trying to achieve a solid customer base and market expansion. Also, the presence of emerging market players positively influences the competition in the industry. The primary competition among the market players accounted for new product launches, emerging, and gold standard formulations.

Abbott, B. Braun SE, Baxter, Danone, Fresenius Kabi AG, Nestle, Perrigo Company plc, and Reckitt Benckiser Group PLC are the leading market players in the global clinical nutrition market. Abbott is a leading clinical nutrition industry player and operates in the adult and pediatric nutrition business segments. The company's brand- Ensure nutrition products portfolio delivers high revenue growth to the adult nutrition business segment. In the nutrition business segment, new flavors and formulations, such as Ensure, Glucerna, Pedialyte, PediaSure, and Similac, include around 360 total care formulas offered by the company.

Key Company Profiles

  • Abbott
  • B. Braun SE
  • Baxter
  • Danone
  • Fresenius Kabi AG
  • Nestle
  • Perrigo Company plc
  • Reckitt Benckiser Group PLC

Other Prominent Vendors

  • ADM
  • Ajinomoto Co., Inc.
  • Aculife
  • Albert David
  • Amanta Healthcare
  • American Regent
  • BML PARENTERAL DRUGS
  • BASF SE
  • Caritas Healthcare
  • DSM
  • Eurofarma
  • Farmoterapica
  • Grifols, S.A.
  • Glanbia PLC
  • Hero Nutritionals
  • HUM Nutrition
  • ICU Medical
  • JW Pharmaceutical
  • Kelun (Sichuan Kelun Pharmaceutical)
  • Kendal Nutricare Limited
  • Lonza
  • Lactalis Nutrition Sante
  • Mend
  • Medifood
  • SternLife GmbH & Co. KG
  • Otsuka Holdings Co. Ltd.
  • Pfizer
  • Primus Pharmaceuticals
  • Soleo Health
  • REVIV
  • The Kraft Heinz Company
  • Vivante Health
  • Vifor Pharma Management

KEY QUESTIONS ANSWERED.

1. What is the growth rate of the global clinical nutrition market?

2. How big is the clinical nutrition market?

3. What are the significant trends in the clinical nutrition industry?

4. Which region dominates the global clinical nutrition market share?

5. Who are the key players in the global clinical nutrition market?

Product Code: ARZ240521

TABLE OF CONTENTS

1 SCOPE & COVERAGE

  • 1.1 MARKET DEFINITION
    • 1.1.1 INCLUSIONS
    • 1.1.2 EXCLUSIONS
    • 1.1.3 MARKET ESTIMATION CAVEATS
  • 1.2 MARKET SEGMENTATION
    • 1.2.1 MARKET BY ROUTE OF ADMINISTRATION
    • 1.2.2 MARKET BY PRODUCT FORM
    • 1.2.3 MARKET BY AGE GROUP
    • 1.2.4 MARKET BY APPLICATION
    • 1.2.5 MARKET BY DISTRIBUTION CHANNELS
    • 1.2.6 MARKET BY END-USERS
    • 1.2.7 REGIONS & COUNTRIES COVERED
  • 1.3 MARKET DERIVATION
    • 1.3.1 HISTORIC, BASE, & FORECAST YEAR

2 PREMIUM INSIGHTS

  • 2.1 OPPORTUNITY POCKETS
  • 2.2 MARKET MATURITY NDICATOR
  • 2.3 VENDOR SPECTRUM
  • 2.4 REGIONAL OUTLOOK
  • 2.5 OVERVIEW
    • 2.5.1 TRENDS & OPPORTUNITIES
    • 2.5.2 MARKET DRIVERS
  • 2.6 MARKET SEGMENTATION

3 MARKET AT A GLANCE

4 INTRODUCTION

  • 4.1 OVERVIEW
  • 4.2 COVID-19 IMPACT ON GLOBAL CLINICAL NUTRITION MARKET
    • 4.2.1 MAJOR IMPACTS OF COVID-19 ON CLINICAL NUTRITION REQUIREMENTS

5 MARKET OPPORTUNITIES & TRENDS

  • 5.1 RISE OF TARGETED & PERSONALIZED NUTRITION
  • 5.2 GROWING R&D FOR NEW COMPOUNDS AND ELEMENTS IN CLINICAL NUTRITION
  • 5.3 ADVANCES IN ENTERAL CLINICAL NUTRITION
  • 5.4 NUTRITIONAL MANAGEMENT SHIFTING TOWARD HOMECARE

6 MARKET GROWTH ENABLERS

  • 6.1 CONSTANT INCREASING POTENTIAL PATIENT POPULATION
  • 6.2 INCREASING BURDEN OF MALNUTRITION
  • 6.3 GROWING NEED FOR CLINICAL NUTRITION IN GERIATRIC POPULATION

7 MARKET RESTRAINTS

  • 7.1 STRINGENT REGULATORY NORMS
  • 7.2 COMPLICATION ASSOCIATED WITH CLINICAL NUTRITION DELIVERY
  • 7.3 IRREGULAR REIMBURSEMENT COVERAGE

8 MARKET LANDSCAPE

  • 8.1 MARKET OVERVIEW
    • 8.1.1 ROUTE OF ADMINISTRATION SEGMENTATION INSIGHTS
    • 8.1.2 PRODUCT FORM SEGMENTATION INSIGHTS
    • 8.1.3 AGE GROUP SEGMENTATION INSIGHTS
    • 8.1.4 APPLICATION SEGMENTATION INSIGHTS
    • 8.1.5 DISTRIBUTION CHANNEL SEGMENTATION INSIGHTS
    • 8.1.6 END-USERS SEGMENTATION INSIGHTS
    • 8.1.7 GEOGRAPHY SEGMENTATION INSIGHTS
  • 8.2 MARKET SIZE & FORECAST
  • 8.3 FIVE FORCES ANALYSIS
    • 8.3.1 THREAT OF NEW ENTRANTS
    • 8.3.2 BARGAINING POWER OF SUPPLIERS
    • 8.3.3 BARGAINING POWER OF BUYERS
    • 8.3.4 THREAT OF SUBSTITUTES
    • 8.3.5 COMPETITIVE RIVALRY

9 ROUTE OF ADMINISTRATION

  • 9.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 9.2 MARKET OVERVIEW
  • 9.3 ORAL
    • 9.3.1 MARKET OVERVIEW
    • 9.3.2 MARKET SIZE & FORECAST
    • 9.3.3 MARKET BY GEOGRAPHY
  • 9.4 ENTERAL
    • 9.4.1 MARKET OVERVIEW
    • 9.4.2 MARKET SIZE & FORECAST
    • 9.4.3 MARKET BY GEOGRAPHY
  • 9.5 PARENTERAL NUTRITION
    • 9.5.1 MARKET OVERVIEW
    • 9.5.2 MARKET SIZE & FORECAST
    • 9.5.3 MARKET BY GEOGRAPHY

10 PRODUCT FORM

  • 10.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 10.2 MARKET OVERVIEW
  • 10.3 POWDER
    • 10.3.1 MARKET OVERVIEW
    • 10.3.2 MARKET SIZE & FORECAST
    • 10.3.3 MARKET BY GEOGRAPHY
  • 10.4 LIQUID
    • 10.4.1 MARKET OVERVIEW
    • 10.4.2 MARKET SIZE & FORECAST
    • 10.4.3 MARKET BY GEOGRAPHY
  • 10.5 SEMI-SOLID
    • 10.5.1 MARKET OVERVIEW
    • 10.5.2 MARKET SIZE & FORECAST
    • 10.5.3 MARKET BY GEOGRAPHY

11 AGE GROUP

  • 11.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 11.2 MARKET OVERVIEW
  • 11.3 CHILDREN & TEENAGER
    • 11.3.1 MARKET OVERVIEW
    • 11.3.2 MARKET SIZE & FORECAST
    • 11.3.3 MARKET BY GEOGRAPHY
  • 11.4 INFANT & TODDLERS
    • 11.4.1 MARKET OVERVIEW
    • 11.4.2 MARKET SIZE & FORECAST
    • 11.4.3 MARKET BY GEOGRAPHY
  • 11.5 ADULT
    • 11.5.1 MARKET OVERVIEW
    • 11.5.2 MARKET SIZE & FORECAST
    • 11.5.3 MARKET BY GEOGRAPHY
  • 11.6 GERIATRIC
    • 11.6.1 MARKET OVERVIEW
    • 11.6.2 MARKET SIZE & FORECAST
    • 11.6.3 MARKET BY GEOGRAPHY

12 APPLICATION

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2 MARKET OVERVIEW
  • 12.3 MALNUTRITION
    • 12.3.1 MARKET OVERVIEW
    • 12.3.2 MARKET SIZE & FORECAST
    • 12.3.3 MARKET BY GEOGRAPHY
  • 12.4 METABOLIC DISEASE
    • 12.4.1 MARKET OVERVIEW
    • 12.4.2 MARKET SIZE & FORECAST
    • 12.4.3 MARKET BY GEOGRAPHY
  • 12.5 GASTROINTESTINAL DISEASES
    • 12.5.1 MARKET OVERVIEW
    • 12.5.2 MARKET SIZE & FORECAST
    • 12.5.3 MARKET BY GEOGRAPHY
  • 12.6 CANCER
    • 12.6.1 MARKET OVERVIEW
    • 12.6.2 MARKET SIZE & FORECAST
    • 12.6.3 MARKET BY GEOGRAPHY
  • 12.7 OTHERS
    • 12.7.1 MARKET OVERVIEW
    • 12.7.2 MARKET SIZE & FORECAST
    • 12.7.3 MARKET BY GEOGRAPHY

13 DISTRIBUTION CHANNELS

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 INSTITUTIONAL SALE CHANNELS
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 PHARMACIES & DRUG STORES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 SUPERMARKETS & HYPERMARKETS
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 ONLINE SALE CHANNELS
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY
  • 13.7 SPECIALTY STORES
    • 13.7.1 MARKET OVERVIEW
    • 13.7.2 MARKET SIZE & FORECAST
    • 13.7.3 MARKET BY GEOGRAPHY
  • 13.8 OTHER DISTRIBUTION CHANNELS
    • 13.8.1 MARKET OVERVIEW
    • 13.8.2 MARKET SIZE & FORECAST
    • 13.8.3 MARKET BY GEOGRAPHY

14 END-USERS

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 HOSPITALS
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 INDIVIDUAL
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 HOMECARE
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY
  • 14.6 LONG-TERM CARE CENTERS
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 MARKET BY GEOGRAPHY

15 GEOGRAPHY

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 GEOGRAPHIC OVERVIEW

16 APAC

  • 16.1 MARKET OVERVIEW
  • 16.2 MARKET SIZE & FORECAST
  • 16.3 ROUTE OF ADMINISTRATION
    • 16.3.1 MARKET SIZE & FORECAST
  • 16.4 PRODUCT FORM
    • 16.4.1 MARKET SIZE & FORECAST
  • 16.5 AGE GROUP
    • 16.5.1 MARKET SIZE & FORECAST
  • 16.6 APPLICATION
    • 16.6.1 MARKET SIZE & FORECAST
  • 16.7 DISTRIBUTION CHANNELS
    • 16.7.1 MARKET SIZE & FORECAST
  • 16.8 END-USERS
    • 16.8.1 MARKET SIZE & FORECAST
  • 16.9 KEY COUNTRIES
  • 16.10 CHINA: MARKET SIZE & FORECAST
  • 16.11 JAPAN: MARKET SIZE & FORECAST
  • 16.12 INDIA: MARKET SIZE & FORECAST
  • 16.13 SOUTH KOREA: MARKET SIZE & FORECAST
  • 16.14 AUSTRALIA: MARKET SIZE & FORECAST
  • 16.15 INDONESIA: MARKET SIZE & FORECAST

17 NORTH AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 ROUTE OF ADMINISTRATION
    • 17.3.1 MARKET SIZE & FORECAST
  • 17.4 PRODUCT FORM
    • 17.4.1 MARKET SIZE & FORECAST
  • 17.5 AGE GROUP
    • 17.5.1 MARKET SIZE & FORECAST
  • 17.6 APPLICATION
    • 17.6.1 MARKET SIZE & FORECAST
  • 17.7 DISTRIBUTION CHANNELS
    • 17.7.1 MARKET SIZE & FORECAST
  • 17.8 END-USERS
    • 17.8.1 MARKET SIZE & FORECAST
  • 17.9 KEY COUNTRIES
  • 17.10 US: MARKET SIZE & FORECAST
  • 17.11 CANADA: MARKET SIZE & FORECAST

18 EUROPE

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 ROUTE OF ADMINISTRATION
    • 18.3.1 MARKET SIZE & FORECAST
  • 18.4 PRODUCT FORM
    • 18.4.1 MARKET SIZE & FORECAST
  • 18.5 AGE GROUP
    • 18.5.1 MARKET SIZE & FORECAST
  • 18.6 APPLICATION
    • 18.6.1 MARKET SIZE & FORECAST
  • 18.7 DISTRIBUTION CHANNELS
    • 18.7.1 MARKET SIZE & FORECAST
  • 18.8 END-USERS
    • 18.8.1 MARKET SIZE & FORECAST
  • 18.9 KEY COUNTRIES
  • 18.10 GERMANY: MARKET SIZE & FORECAST
  • 18.11 UK: MARKET SIZE & FORECAST
  • 18.12 FRANCE: MARKET SIZE & FORECAST
  • 18.13 ITALY: MARKET SIZE & FORECAST
  • 18.14 SPAIN: MARKET SIZE & FORECAST
  • 18.15 RUSSIA: MARKET SIZE & FORECAST
  • 18.16 POLAND: MARKET SIZE & FORECAST

19 LATIN AMERICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 ROUTE OF ADMINISTRATION
    • 19.3.1 MARKET SIZE & FORECAST
  • 19.4 PRODUCT FORM
    • 19.4.1 MARKET SIZE & FORECAST
  • 19.5 AGE GROUP
    • 19.5.1 MARKET SIZE & FORECAST
  • 19.6 APPLICATION
    • 19.6.1 MARKET SIZE & FORECAST
  • 19.7 DISTRIBUTION CHANNELS
    • 19.7.1 MARKET SIZE & FORECAST
  • 19.8 END-USERS
    • 19.8.1 MARKET SIZE & FORECAST
  • 19.9 KEY COUNTRIES
  • 19.10 BRAZIL: MARKET SIZE & FORECAST
  • 19.11 MEXICO: MARKET SIZE & FORECAST
  • 19.12 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 ROUTE OF ADMINISTRATION
    • 20.3.1 MARKET SIZE & FORECAST
  • 20.4 PRODUCT FORM
    • 20.4.1 MARKET SIZE & FORECAST
  • 20.5 AGE GROUP
    • 20.5.1 MARKET SIZE & FORECAST
  • 20.6 APPLICATION
    • 20.6.1 MARKET SIZE & FORECAST
  • 20.7 DISTRIBUTION CHANNELS
    • 20.7.1 MARKET SIZE & FORECAST
  • 20.8 END-USERS
    • 20.8.1 MARKET SIZE & FORECAST
  • 20.9 KEY COUNTRIES
  • 20.10 TURKEY: MARKET SIZE & FORECAST
  • 20.11 SAUDI ARABIA: MARKET SIZE & FORECAST
  • 20.12 SOUTH AFRICA: MARKET SIZE & FORECAST
  • 20.13 EGYPT: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

  • 21.1 COMPETITION OVERVIEW
  • 21.2 MARKET SHARE ANALYSIS
    • 21.2.1 ABBOTT
    • 21.2.2 B. BRAUN
    • 21.2.3 BAXTER
    • 21.2.4 DANONE
    • 21.2.5 FRESENIUS KABI AG
    • 21.2.6 NESTLE
    • 21.2.7 PERRIGO COMPANY PLC
    • 21.2.8 RECKITT BENCKISER GROUP

22 KEY COMPANY PROFILES

  • 22.1 ABBOTT
    • 22.1.1 BUSINESS OVERVIEW
    • 22.1.2 PRODUCT OFFERINGS
    • 22.1.3 KEY STRATEGIES
    • 22.1.4 KEY STRENGTHS
    • 22.1.5 KEY OPPORTUNITIES
  • 22.2 B. BRAUN SE
    • 22.2.1 BUSINESS OVERVIEW
    • 22.2.2 PRODUCT OFFERINGS
    • 22.2.3 KEY STRATEGIES
    • 22.2.4 KEY STRENGTHS
    • 22.2.5 KEY OPPORTUNITIES
  • 22.3 BAXTER
    • 22.3.1 BUSINESS OVERVIEW
    • 22.3.2 PRODUCT OFFERINGS
    • 22.3.3 KEY STRATEGIES
    • 22.3.4 KEY STRENGTHS
    • 22.3.5 KEY OPPORTUNITIES
  • 22.4 DANONE
    • 22.4.1 BUSINESS OVERVIEW
    • 22.4.2 PRODUCT OFFERINGS
    • 22.4.3 KEY STRATEGIES
    • 22.4.4 KEY STRENGTHS
    • 22.4.5 KEY OPPORTUNITIES
  • 22.5 FRESENIUS KABI AG
    • 22.5.1 BUSINESS OVERVIEW
    • 22.5.2 PRODUCT OFFERINGS
    • 22.5.3 KEY STRATEGIES
    • 22.5.4 KEY STRENGTHS
    • 22.5.5 KEY OPPORTUNITIES
  • 22.6 NESTLE
    • 22.6.1 BUSINESS OVERVIEW
    • 22.6.2 PRODUCT OFFERINGS
    • 22.6.3 KEY STRATEGIES
    • 22.6.4 KEY STRENGTHS
    • 22.6.5 KEY OPPORTUNITIES
  • 22.7 PERRIGO COMPANY PLC
    • 22.7.1 BUSINESS OVERVIEW
    • 22.7.2 PRODUCT OFFERINGS
    • 22.7.3 KEY STRATEGIES
    • 22.7.4 KEY STRENGTHS
    • 22.7.5 KEY OPPORTUNITIES
  • 22.8 RECKITT BENCKISER GROUP PLC
    • 22.8.1 BUSINESS OVERVIEW
    • 22.8.2 PRODUCT OFFERINGS
    • 22.8.3 KEY STRATEGIES
    • 22.8.4 KEY STRENGTHS
    • 22.8.5 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

  • 23.1 ADM
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 PRODUCT OFFERINGS
  • 23.2 AJINOMOTO CO., INC.
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 PRODUCT OFFERINGS
  • 23.3 ACULIFE
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 PRODUCT OFFERINGS
  • 23.4 ALBERT DAVID
    • 23.4.1 BUSINESS OVERVIEW
    • 23.4.2 PRODUCT OFFERINGS
  • 23.5 AMANTA HEALTHCARE
    • 23.5.1 BUSINESS OVERVIEW
    • 23.5.2 PRODUCT OFFERINGS
  • 23.6 AMERICAN REGENT
    • 23.6.1 BUSINESS OVERVIEW
    • 23.6.2 PRODUCT OFFERINGS
  • 23.7 BML PARENTERAL DRUGS
    • 23.7.1 BUSINESS OVERVIEW
    • 23.7.2 PRODUCT OFFERINGS
  • 23.8 BASF SE
    • 23.8.1 BUSINESS OVERVIEW
    • 23.8.2 PRODUCT OFFERINGS
  • 23.9 CARITAS HEALTHCARE
    • 23.9.1 BUSINESS OVERVIEW
    • 23.9.2 PRODUCT OFFERINGS
  • 23.10 CSL VIFOR
    • 23.10.1 BUSINESS OVERVIEW
    • 23.10.2 PRODUCT OFFERINGS
  • 23.11 DSM
    • 23.11.1 BUSINESS OVERVIEW
    • 23.11.2 PRODUCT OFFERINGS
  • 23.12 EUROFARMA
    • 23.12.1 BUSINESS OVERVIEW
    • 23.12.2 PRODUCT OFFERINGS
  • 23.13 FARMOTERAPICA
    • 23.13.1 BUSINESS OVERVIEW
    • 23.13.2 PRODUCT OFFERINGS
  • 23.14 GRIFOLS, S.A.
    • 23.14.1 BUSINESS OVERVIEW
    • 23.14.2 PRODUCT OFFERINGS
  • 23.15 GLANBIA PLC
    • 23.15.1 BUSINESS OVERVIEW
    • 23.15.2 PRODUCT OFFERINGS
  • 23.16 HERO NUTRITIONALS
    • 23.16.1 BUSINESS OVERVIEW
    • 23.16.2 PRODUCT OFFERINGS
  • 23.17 HUM NUTRITION
    • 23.17.1 BUSINESS OVERVIEW
    • 23.17.2 PRODUCT OFFERINGS
  • 23.18 ICU MEDICAL
    • 23.18.1 BUSINESS OVERVIEW
    • 23.18.2 PRODUCT OFFERINGS
  • 23.19 JW PHARMACEUTICAL
    • 23.19.1 BUSINESS OVERVIEW
    • 23.19.2 PRODUCT OFFERINGS
  • 23.20 KELUN (SICHUAN KELUN PHARMACEUTICALS)
    • 23.20.1 BUSINESS OVERVIEW
    • 23.20.2 PRODUCT OFFERINGS
  • 23.21 KENDAL NUTRICARE LIMITED
    • 23.21.1 BUSINESS OVERVIEW
    • 23.21.2 PRODUCT OFFERINGS
  • 23.22 LONZA
    • 23.22.1 BUSINESS OVERVIEW
    • 23.22.2 PRODUCT OFFERINGS
  • 23.23 MEND
    • 23.23.1 BUSINESS OVERVIEW
    • 23.23.2 PRODUCT OFFERINGS
  • 23.24 MEDIFOOD
    • 23.24.1 BUSINESS OVERVIEW
    • 23.24.2 PRODUCT OFFERINGS
  • 23.25 STERNLIFE GMBH & CO. KG
    • 23.25.1 BUSINESS OVERVIEW
    • 23.25.2 PRODUCT OFFERINGS
  • 23.26 OTSUKA HOLDINGS CO. LTD.
    • 23.26.1 BUSINESS OVERVIEW
    • 23.26.2 PRODUCT OFFERINGS
  • 23.27 PFIZER
    • 23.27.1 BUSINESS OVERVIEW
    • 23.27.2 PRODUCT OFFERINGS
  • 23.28 PRIMUS PHARMACEUTICALS
    • 23.28.1 BUSINESS OVERVIEW
    • 23.28.2 PRODUCT OFFERINGS
  • 23.29 REVIV
    • 23.29.1 BUSINESS OVERVIEW
    • 23.29.2 PRODUCT OFFERINGS
  • 23.30 SOLEO HEALTH
    • 23.30.1 BUSINESS OVERVIEW
    • 23.30.2 PRODUCT OFFERINGS
  • 23.31 SOLACE NUTRITION
    • 23.31.1 BUSINESS OVERVIEW
    • 23.31.2 PRODUCT OFFERINGS
  • 23.32 THE KRAFT HEINZ COMPANY
    • 23.32.1 BUSINESS OVERVIEW
    • 23.32.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

  • 24.1 KEY TAKEAWAYS
  • 24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

  • 25.1 MARKET BY GEOGRAPHY
  • 25.2 MARKET BY ROUTE OF ADMINISTRATION
  • 25.3 MARKET BY PRODUCT FORM
  • 25.4 MARKET BY AGE GROUP
  • 25.5 MARKET BY APPLICATION
  • 25.6 MARKET BY DISTRIBUTION CHANNELS
  • 25.7 MARKET BY END-USERS
  • 25.8 ROUTE OF ADMINISTRATION: MARKET BY GEOGRAPHY
    • 25.8.1 ORAL
    • 25.8.2 ENTERAL
    • 25.8.3 PARENTERAL
  • 25.9 PRODUCT FORM: MARKET BY GEOGRAPHY
    • 25.9.1 POWDER
    • 25.9.2 LIQUID
    • 25.9.3 SEMI-SOLID
  • 25.10 AGE GROUP: MARKET BY GEOGRAPHY
    • 25.10.1 CHILDREN & TEENAGERS
    • 25.10.2 INFANTS & TODDLERS
    • 25.10.3 ADULTS
    • 25.10.4 GERIATRIC
  • 25.11 APPLICATION: MARKET BY GEOGRAPHY
    • 25.11.1 MALNUTRITION
    • 25.11.2 METABOLIC DISORDERS
    • 25.11.3 GASTROINTESTINAL DISORDERS
    • 25.11.4 CANCER
    • 25.11.5 OTHER APPLICATIONS
  • 25.12 DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
    • 25.12.1 INSTITUTIONAL SALES CHANNELS
    • 25.12.2 PHARMACIES & DRUG STORES
    • 25.12.3 SUPERMARKETS & HYPERMARKETS
    • 25.12.4 ONLINE SALES CHANNELS
    • 25.12.5 SPECIALTY STORES
    • 25.12.6 OTHER DISTRIBUTION CHANNELS
  • 25.13 END-USERS: MARKET BY GEOGRAPHY
    • 25.13.1 HOSPITALS
    • 25.13.2 INDIVIDUALS
    • 25.13.3 HOMECARE
    • 25.13.4 LTC

26 APPENDIX

  • 26.1 RESEARCH METHODOLOGY
  • 26.2 RESEARCH PROCESS
  • 26.3 REPORT ASSUMPTIONS & CAVEATS
    • 26.3.1 KEY CAVEATS
    • 26.3.2 CURRENCY CONVERSION
  • 26.4 ABBREVIATIONS
Product Code: ARZ240521

List Of Exhibits

LIST OF EXHIBITS

  • EXHIBIT 1 MARKET SIZE CALCULATION APPROACH (2023)
  • EXHIBIT 2 NUTRITION DISORDERS AND NUTRITION ASSOCIATED CONDITIONS
  • EXHIBIT 3 COVID-19 AND MALNUTRITION
  • EXHIBIT 4 IMPACT OF RISE OF TARGETED & PERSONALIZED NUTRITION
  • EXHIBIT 5 PERSONALIZED & TARGETED NUTRITION TYPES AND ASSOCIATED BENEFITS
  • EXHIBIT 6 DANONE SPECIALIZED NUTRITION SALE 2018-2020 ($ BILLION)
  • EXHIBIT 7 IMPACT OF GROWING R&D FOR NEW COMPOUNDS AND ELEMENTS IN CLINICAL NUTRITION
  • EXHIBIT 8 IMPACT OF ADVANCES IN ENTERAL CLINICAL NUTRITION
  • EXHIBIT 9 RECENT DEVELOPMENTS IN ENTERAL NUTRITION
  • EXHIBIT 10 IMPACT OF NUTRITIONAL MANAGEMENT SHIFTING TOWARD HOMECARE NUTRITION
  • EXHIBIT 11 IMPACT OF CONSTANT INCREASING POTENTIAL PATIENT POPULATION
  • EXHIBIT 12 IMPACT OF INCREASING BURDEN OF MALNUTRITION
  • EXHIBIT 13 GLOBAL & REGIONAL STUNTING PREVALENCE (%) 2012-2022
  • EXHIBIT 14 IMPACT OF GROWING NEED FOR CLINICAL NUTRITION IN GERIATRIC POPULATION
  • EXHIBIT 15 IMPACT OF STRINGENT REGULATORY NORMS
  • EXHIBIT 16 IMPACT OF COMPLICATIONS ASSOCIATED WITH CLINICAL NUTRITION DELIVERY
  • EXHIBIT 17 IMPACT OF IRREGULAR REIMBURSEMENT COVERAGE
  • EXHIBIT 18 GLOBAL CLINICAL NUTRITION MARKET SEGMENTATION
  • EXHIBIT 19 GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION
  • EXHIBIT 20 GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT FORM
  • EXHIBIT 21 GLOBAL CLINICAL NUTRITION MARKET BY AGE GROUP
  • EXHIBIT 22 GLOBAL CLINICAL NUTRITION MARKET BY APPLICATION
  • EXHIBIT 23 GLOBAL CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNEL
  • EXHIBIT 24 GLOBAL CLINICAL NUTRITION MARKET BY END-USER
  • EXHIBIT 25 GLOBAL CLINICAL NUTRITION MARKET BY GEOGRAPHY
  • EXHIBIT 26 GLOBAL CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 27 FIVE FORCES ANALYSIS (2023)
  • EXHIBIT 28 INCREMENTAL GROWTH BY ROUTE OF ADMINISTRATION (2023 & 2029)
  • EXHIBIT 29 GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION (2023-2029)
  • EXHIBIT 30 GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION: INCREMENTAL GROWTH
  • EXHIBIT 31 GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION: ABSOLUTE GROWTH
  • EXHIBIT 32 GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION: SEGMENTAL OVERVIEW
  • EXHIBIT 33 GLOBAL ORAL CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 34 GLOBAL ORAL CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 35 ENTERAL NUTRITION DELIVERY STATISTICS
  • EXHIBIT 36 GLOBAL ENTERAL CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 37 GLOBAL ENTERAL CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 38 GLOBAL PARENTERAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 39 GLOBAL PARENTERAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 40 INCREMENTAL GROWTH BY PRODUCT FORM (2023 & 2029)
  • EXHIBIT 41 GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT FORM (2023-2029)
  • EXHIBIT 42 GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT FORM: INCREMENTAL GROWTH
  • EXHIBIT 43 GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT FORM: ABSOLUTE GROWTH
  • EXHIBIT 44 GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT FORM: SEGMENTAL OVERVIEW
  • EXHIBIT 45 GLOBAL POWDER FORM CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 46 GLOBAL POWDER FORM CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 47 GLOBAL LIQUID FORM CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 48 GLOBAL LIQUID FORM CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 49 SEMI-SOLID ORAL NUTRITIONAL SUPPLEMENTS FOR VARIOUS CLINICAL INDICATIONS
  • EXHIBIT 50 GLOBAL SEMI-SOLID CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 51 GLOBAL SEMI-SOLID CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 52 INCREMENTAL GROWTH BY AGE GROUP (2023 & 2029)
  • EXHIBIT 53 GLOBAL CLINICAL NUTRITION MARKET BY AGE GROUP (2023-2029)
  • EXHIBIT 54 GLOBAL CLINICAL NUTRITION MARKET BY AGE GROUP: INCREMENTAL GROWTH
  • EXHIBIT 55 WORLDWIDE CHILDREN UNDER AGE FIVE MALNUTRITION PREVALENCE 2000 & 2022 (%)
  • EXHIBIT 56 OBESITY PREVALENCE AMONG US CHILDREN & TEENAGE FROM 1970 TO 2022
  • EXHIBIT 57 GLOBAL CHILD & TEENAGER CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 58 GLOBAL CHILD & TEENAGER CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 59 GLOBAL PRETERM BIRTH STATISTICS (2022)
  • EXHIBIT 60 GLOBAL INFANT & TODDLER CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 61 GLOBAL INFANT & TODDLER CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 62 GLOBAL ADULT CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 63 GLOBAL ADULT CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 64 GLOBAL GERIATRIC CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 65 GLOBAL GERIATRIC CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 66 INCREMENTAL GROWTH BY APPLICATION (2023 & 2029)
  • EXHIBIT 67 GLOBAL CLINICAL NUTRITION MARKET BY APPLICATION (2023-2029)
  • EXHIBIT 68 GLOBAL CLINICAL NUTRITION MARKET BY APPLICATION: INCREMENTAL GROWTH
  • EXHIBIT 69 GLOBAL CLINICAL NUTRITION MARKET BY APPLICATION: ABSOLUTE GROWTH
  • EXHIBIT 70 DISEASE RELATED MALNUTRITION & ASSOCIATED HEALTH IMPACTS
  • EXHIBIT 71 GLOBAL MALNUTRITION CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 72 GLOBAL MALNUTRITION CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 73 GLOBAL METABOLIC DISORDERS CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 74 GLOBAL METABOLIC DISORDERS CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 75 GLOBAL GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 76 GLOBAL GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 77 GLOBAL CANCER STATISTICS
  • EXHIBIT 78 GLOBAL CANCER CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 79 GLOBAL CANCER CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 80 GLOBAL OTHER APPLICATIONS CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 81 GLOBAL OTHER APPLICATIONS CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 82 INCREMENTAL GROWTH BY DISTRIBUTION CHANNELS (2023 & 2029)
  • EXHIBIT 83 GLOBAL CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS (2023-2029)
  • EXHIBIT 84 GLOBAL CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS: INCREMENTAL GROWTH
  • EXHIBIT 85 GLOBAL CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS: ABSOLUTE GROWTH
  • EXHIBIT 86 GLOBAL INSTITUTIONAL SALE CHANNELS CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 87 GLOBAL INSTITUTIONAL SALE CHANNELS CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 88 TOP COUNTRIES WITH THE MOST PHARMACIES (2023)
  • EXHIBIT 89 GLOBAL PHARMACIES & DRUG STORES CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 90 GLOBAL PHARMACIES & DRUG STORES CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 91 GLOBAL SUPERMARKETS & HYPERMARKETS CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 92 GLOBAL SUPERMARKETS & HYPERMARKETS CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 93 GLOBAL ONLINE SALE CHANNELS CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 94 GLOBAL ONLINE SALE CHANNELS CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 95 GLOBAL SPECIALTY STORES CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 96 GLOBAL SPECIALTY STORES CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 97 GLOBAL OTHER DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 98 GLOBAL OTHER DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 99 INCREMENTAL GROWTH BY END-USERS (2023 & 2029)
  • EXHIBIT 100 GLOBAL CLINICAL NUTRITION MARKET BY END-USERS (2023-2029)
  • EXHIBIT 101 GLOBAL CLINICAL NUTRITION MARKET BY END-USERS: INCREMENTAL GROWTH
  • EXHIBIT 102 GLOBAL CLINICAL NUTRITION MARKET BY END-USERS: ABSOLUTE GROWTH
  • EXHIBIT 103 GLOBAL HOSPITALS CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 104 GLOBAL HOSPITALS CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 105 GLOBAL INDIVIDUAL CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 106 GLOBAL INDIVIDUAL CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 107 GLOBAL HOMECARE CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 108 GLOBAL HOMECARE CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 109 GLOBAL LONG-TERM CARE CENTERS CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 110 GLOBAL LONG-TERM CARE CENTERS CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 111 INCREMENTAL GROWTH BY GEOGRAPHY (2023 & 2029)
  • EXHIBIT 112 GLOBAL CLINICAL NUTRITION MARKET BY GEOGRAPHY (2020-2029)
  • EXHIBIT 113 GLOBAL CLINICAL NUTRITION MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
  • EXHIBIT 114 GLOBAL CLINICAL NUTRITION MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
  • EXHIBIT 115 APAC CLINICAL NUTRITION MARKET: KEY COUNTRIES REVENUE 2023 ($ BILLION)
  • EXHIBIT 116 APAC CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 117 CLINICAL NUTRITION MARKET IN APAC 2020-2029 ($ BILLION)
  • EXHIBIT 118 INCREMENTAL GROWTH IN APAC (2023 & 2029)
  • EXHIBIT 119 CLINICAL NUTRITION MARKET IN CHINA 2020-2029 ($ BILLION)
  • EXHIBIT 120 CLINICAL NUTRITION MARKET IN JAPAN 2020-2029 ($ BILLION)
  • EXHIBIT 121 CLINICAL NUTRITION MARKET IN INDIA 2020-2029 ($ BILLION)
  • EXHIBIT 122 CLINICAL NUTRITION MARKET IN SOUTH KOREA 2020-2029 ($ BILLION)
  • EXHIBIT 123 CLINICAL NUTRITION MARKET IN AUSTRALIA 2020-2029 ($ BILLION)
  • EXHIBIT 124 CLINICAL NUTRITION MARKET IN INDONESIA 2020-2029 ($ BILLION)
  • EXHIBIT 125 NORTH AMERICA CLINICAL NUTRITION MARKET: KEY COUNTRIES REVENUE 2023 ($ BILLION)
  • EXHIBIT 126 NORTH AMERICA CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 127 CLINICAL NUTRITION MARKET IN NORTH AMERICA 2020-2029 ($ BILLION)
  • EXHIBIT 128 INCREMENTAL GROWTH IN NORTH AMERICA (2023 & 2029)
  • EXHIBIT 129 US NUTRITIONAL FACTS (2022)
  • EXHIBIT 130 US CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 131 CLINICAL NUTRITION MARKET IN CANADA 2020-2029 ($ BILLION)
  • EXHIBIT 132 EUROPE MALNUTRITION BURDEN (2022)
  • EXHIBIT 133 EUROPE CLINICAL NUTRITION MARKET: KEY COUNTRIES REVENUE 2023 ($ BILLION)S
  • EXHIBIT 134 POTENTIAL GROWTH FACTORS FOR CLINICAL NUTRITION IN EUROPE (2023)
  • EXHIBIT 135 DIABETES PREVALENCE IN EUROPEAN UNION 200 TO 2019 AND 2030 (PREDICTED)
  • EXHIBIT 136 EUROPE CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 137 CLINICAL NUTRITION MARKET IN EUROPE 2020-2029 ($ BILLION)
  • EXHIBIT 138 INCREMENTAL GROWTH IN EUROPE (2023 & 2029)
  • EXHIBIT 139 CLINICAL NUTRITION MARKET IN GERMANY 2020-2029 ($ BILLION)
  • EXHIBIT 140 UK CLINICAL NUTRITION MARKET 2020-2029 ($ BILLION)
  • EXHIBIT 141 CLINICAL NUTRITION MARKET IN FRANCE 2020-2029 ($ BILLION)
  • EXHIBIT 142 CLINICAL NUTRITION MARKET IN ITALY 2020-2029 ($ BILLION)
  • EXHIBIT 143 SPAIN: DISEASE RELATED MALNUTRITION PREVALENCE 2021 (%)
  • EXHIBIT 144 CLINICAL NUTRITION MARKET IN SPAIN 2020-2029 ($ BILLION)
  • EXHIBIT 145 CLINICAL NUTRITION MARKET IN RUSSIA 2020-2029 ($ BILLION)
  • EXHIBIT 146 CLINICAL NUTRITION MARKET IN POLAND 2020-2029 ($ BILLION)
  • EXHIBIT 147 LATIN AMERICA CLINICAL NUTRITION MARKET: KEY COUNTRIES REVENUE 2023 ($ BILLION)
  • EXHIBIT 148 LATIN AMERICA CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 149 CLINICAL NUTRITION MARKET IN LATIN AMERICA 2020-2029 ($ BILLION)
  • EXHIBIT 150 INCREMENTAL GROWTH IN LATIN AMERICA (2023 & 2029)
  • EXHIBIT 151 CLINICAL NUTRITION MARKET IN BRAZIL 2020-2029 ($ BILLION)
  • EXHIBIT 152 CLINICAL NUTRITION MARKET IN MEXICO 2020-2029 ($ BILLION)
  • EXHIBIT 153 CLINICAL NUTRITION MARKET IN ARGENTINA 2020-2029 ($ BILLION)
  • EXHIBIT 154 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET: KEY COUNTRIES REVENUE 2023 ($ BILLION)
  • EXHIBIT 155 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 156 CLINICAL NUTRITION MARKET IN MIDDLE EAST & AFRICA 2020-2029 ($ BILLION)
  • EXHIBIT 157 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA (2023 & 2029)
  • EXHIBIT 158 CLINICAL NUTRITION MARKET IN TURKEY 2020-2029 ($ BILLION)
  • EXHIBIT 159 CHRONIC CONDITION WITH HIGHER BURDEN IN SAUDI ARABIA 2023 (CASES PER 100,000 PEOPLE)
  • EXHIBIT 160 CLINICAL NUTRITION MARKET IN SAUDI ARABIA 2020-2029 ($ BILLION)
  • EXHIBIT 161 CLINICAL NUTRITION MARKET IN SOUTH AFRICA 2020-2029 ($ BILLION)
  • EXHIBIT 162 CLINICAL NUTRITION MARKET IN EGYPT 2020-2029 ($ BILLION)
  • EXHIBIT 163 VENDORS OFFERING CLINICAL NUTRITION PRODUCTS: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 164 VENDORS OFFERING CLINICAL NUTRITION PRODUCTS: CAPABILITIES & EXPERT ASSESSMENT
  • EXHIBIT 165 ABBOTT ANNUAL REVENUE 2019-2023 ($ BILLION)
  • EXHIBIT 166 ABBOTT ANNUAL REVENUE BY NUTRITIONAL PRODUCT CATEGORY SALE 2020-2023 ($ MILLION)
  • EXHIBIT 167 B. BRAUN SE ANNUAL REVENUE 2019-2023 ($ BILLION)
  • EXHIBIT 168 BAXTER ANNUAL REVENUE 2019-2023 ($ BILLION)
  • EXHIBIT 169 DANONE ANNUAL REVENUE 2021-2023 ($ BILLION)
  • EXHIBIT 170 FRESENIUS KABI TOTAL ANNUAL REVENUE 2019-2023 ($ BILLION)
  • EXHIBIT 171 FRESENIUS KABI AG ANNUAL REVENUE 2021-2023 ($ MILLION)
  • EXHIBIT 172 NESTLE ANNUL REVENUE 2019-2023 ($ BILLION)
  • EXHIBIT 173 PERRIGO COMPANY PLC ANNUAL REVENUE 2019-2023 ($ BILLION)
  • EXHIBIT 174 PERRIGO COMPANY PLC ANNUAL REVENUE BY NUTRITION PRODUCT CATEGORY 2019-2023 ($ MILLION)
  • EXHIBIT 175 RECKITT BENCKISER GROUP PLC ANNUAL REVENUE 2019-2023 ($ BILLION)
  • EXHIBIT 176 KEY CAVEATS

List Of Tables

LIST OF TABLES

  • TABLE 1 AGING POPULATION IN SELECTED APAC COUNTRIES (2022)
  • TABLE 2 GLOBAL ORAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 3 GLOBAL ORAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 4 GLOBAL ENTERAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 5 GLOBAL ENTERAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 6 GLOBAL PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 7 GLOBAL PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 8 GLOBAL POWDER FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 9 GLOBAL POWDER FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 10 GLOBAL LIQUID FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 11 GLOBAL LIQUID FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 12 GLOBAL SEMI-SOLID CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 13 GLOBAL SEMI-SOLID CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 14 GLOBAL CHILD & TEENAGER CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 15 GLOBAL CHILD & TEENAGER CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 16 GLOBAL INFANT & TODDLER CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 17 GLOBAL INFANT & TODDLER CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 18 GLOBAL ADULT CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 19 GLOBAL ADULT CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 20 GLOBAL GERIATRIC CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 21 GLOBAL GERIATRIC CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 22 GLOBAL MALNUTRITION CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 23 GLOBAL MALNUTRITION CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 24 GLOBAL METABOLIC DISORDERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 25 GLOBAL METABOLIC DISORDERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 26 GLOBAL GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 27 GLOBAL GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 28 GLOBAL CANCER CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 29 GLOBAL CANCER CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 30 GLOBAL OTHER APPLICATIONS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 31 GLOBAL OTHER APPLICATIONS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 32 GLOBAL INSTITUTIONAL SALE CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 33 GLOBAL INSTITUTIONAL SALE CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 34 GLOBAL PHARMACIES & DRUG STORES CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 35 GLOBAL PHARMACIES & DRUG STORES CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 36 GLOBAL SUPERMARKETS & HYPERMARKETS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 37 GLOBAL SUPERMARKETS & HYPERMARKETS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 38 GLOBAL ONLINE SALE CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 39 GLOBAL ONLINE SALE CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 40 GLOBAL SPECIALTY STORES CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 41 GLOBAL SPECIALTY STORES CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 42 GLOBAL OTHER DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 43 GLOBAL OTHER DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 44 GLOBAL HOSPITALS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 45 GLOBAL HOSPITALS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 46 GLOBAL INDIVIDUAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 47 GLOBAL INDIVIDUAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 48 GLOBAL HOMECARE CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 49 GLOBAL HOMECARE CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 50 GLOBAL LONG-TERM CARE CENTERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 51 GLOBAL LONG-TERM CARE CENTERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 52 APAC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 ($ BILLION)
  • TABLE 53 APAC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 (%)
  • TABLE 54 APAC CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 ($ BILLION)
  • TABLE 55 APAC CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 (%)
  • TABLE 56 APAC CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 ($ BILLION)
  • TABLE 57 APAC CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 (%)
  • TABLE 58 APAC CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 ($ BILLION)
  • TABLE 59 APAC CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 60 APAC CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 ($ BILLION)
  • TABLE 61 APAC CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 (%)
  • TABLE 62 APAC CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 ($ BILLION)
  • TABLE 63 APAC CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 (%)
  • TABLE 64 NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 ($ BILLION)
  • TABLE 65 NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 (%)
  • TABLE 66 NORTH AMERICA CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 ($ BILLION)
  • TABLE 67 NORTH AMERICA CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 (%)
  • TABLE 68 NORTH AMERICA CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 ($ BILLION)
  • TABLE 69 NORTH AMERICA CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 (%)
  • TABLE 70 NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 ($ BILLION)
  • TABLE 71 NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 72 NORTH AMERICA CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 ($ BILLION)
  • TABLE 73 NORTH AMERICA CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 (%)
  • TABLE 74 NORTH AMERICA CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 ($ BILLION)
  • TABLE 75 NORTH AMERICA CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 (%)
  • TABLE 76 EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 ($ BILLION)
  • TABLE 77 EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 (%)
  • TABLE 78 EUROPE CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 ($ BILLION)
  • TABLE 79 EUROPE CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 (%)
  • TABLE 80 EUROPE CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 ($ BILLION)
  • TABLE 81 EUROPE CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 (%)
  • TABLE 82 EUROPE CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 ($ BILLION)
  • TABLE 83 EUROPE CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 84 EUROPE CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 ($ BILLION)
  • TABLE 85 EUROPE CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 (%)
  • TABLE 86 EUROPE CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 ($ BILLION)
  • TABLE 87 EUROPE CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 (%)
  • TABLE 88 LATIN AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 ($ BILLION)
  • TABLE 89 LATIN AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 (%)
  • TABLE 90 LATIN AMERICA CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 ($ BILLION)
  • TABLE 91 LATIN AMERICA CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 (%)
  • TABLE 92 LATIN AMERICA CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 ($ BILLION)
  • TABLE 93 LATIN AMERICA CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 (%)
  • TABLE 94 LATIN AMERICA CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 ($ BILLION)
  • TABLE 95 LATIN AMERICA CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 96 LATIN AMERICA CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 ($ BILLION)
  • TABLE 97 LATIN AMERICA CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 (%)
  • TABLE 98 LATIN AMERICA CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 ($ BILLION)
  • TABLE 99 LATIN AMERICA CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 (%)
  • TABLE 100 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 ($ BILLION)
  • TABLE 101 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 (%)
  • TABLE 102 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 ($ BILLION)
  • TABLE 103 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 (%)
  • TABLE 104 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 ($ BILLION)
  • TABLE 105 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 (%)
  • TABLE 106 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 ($ BILLION)
  • TABLE 107 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 108 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 ($ BILLION)
  • TABLE 109 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 (%)
  • TABLE 110 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 ($ BILLION)
  • TABLE 111 MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 (%)
  • TABLE 112 SOME LEADING COMPANIES IN CLINICAL NUTRITION MARKET WITH THEIR ANNUAL REVENUE ($ BILLION)
  • TABLE 113 ABBOTT NUTRITION BUSINESS SEGMENT REVENUE ($ MILLION)
  • TABLE 114 BAXTER CLINICAL NUTRITION REVENUE ($ MILLION)
  • TABLE 115 ABBOTT: MAJOR PRODUCT OFFERINGS
  • TABLE 116 B. BRAUN SE: MAJOR PRODUCT OFFERINGS
  • TABLE 117 BAXTER: MAJOR PRODUCT OFFERINGS
  • TABLE 118 DANONE: MAJOR PRODUCT OFFERINGS
  • TABLE 119 FRESENIUS KABI AG: MAJOR PRODUCT OFFERINGS
  • TABLE 120 NESTLE: MAJOR PRODUCT OFFERINGS
  • TABLE 121 PERRIGO COMPANY PLC: MAJOR PRODUCT OFFERINGS
  • TABLE 122 RECKITT BENCKISER GROUP PLC: MAJOR PRODUCT OFFERINGS
  • TABLE 123 ADM: MAJOR PRODUCT OFFERINGS
  • TABLE 124 AJINOMOTO CO., INC., MAJOR PRODUCT OFFERINGS
  • TABLE 125 ACULIFE: MAJOR PRODUCT OFFERINGS
  • TABLE 126 ALBERT DAVID: MAJOR PRODUCT OFFERINGS
  • TABLE 127 AMANTA HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 128 AMERICAN REGENT: MAJOR PRODUCT OFFERINGS
  • TABLE 129 BML PARENTERAL DRUGS: MAJOR PRODUCT OFFERINGS
  • TABLE 130 BASF SE: MAJOR PRODUCT OFFERINGS
  • TABLE 131 CARITAS HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 132 CSL VIFOR: MAJOR PRODUCT OFFERINGS
  • TABLE 133 DSM: MAJOR PRODUCT OFFERINGS
  • TABLE 134 EUROFARMA: MAJOR PRODUCT OFFERINGS
  • TABLE 135 FARMOTERAPICA: MAJOR PRODUCT OFFERINGS
  • TABLE 136 GRIFOLS, S.A.: MAJOR PRODUCT OFFERINGS
  • TABLE 137 GLANBIA PLC: MAJOR PRODUCT OFFERINGS
  • TABLE 138 HERO NUTRITIONALS: MAJOR PRODUCT OFFERINGS
  • TABLE 139 HUM NUTRITION: MAJOR PRODUCT OFFERINGS
  • TABLE 140 ICU MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 141 JW PHARMACEUTICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 142 KELUN (SICHUAN KELUN PHARMACEUTICAL): MAJOR PRODUCT OFFERINGS
  • TABLE 143 KENDAL NUTRICARE LIMITED: MAJOR PRODUCT OFFERINGS
  • TABLE 144 LONZA: MAJOR PRODUCT OFFERINGS
  • TABLE 145 MEND: MAJOR PRODUCT OFFERINGS
  • TABLE 146 MEDIFOOD: MAJOR PRODUCT OFFERINGS
  • TABLE 147 STERNLIFE GMBH & CO. KG: MAJOR PRODUCT OFFERINGS
  • TABLE 148 OTSUKA HOLDINGS CO. LTD.: MAJOR PRODUCT OFFERINGS
  • TABLE 149 PFIZER: MAJOR PRODUCT OFFERINGS
  • TABLE 150 PRIMUS PHARMACEUTICALS: MAJOR PRODUCT OFFERINGS
  • TABLE 151 REVIV: MAJOR PRODUCT OFFERINGS
  • TABLE 152 SOLEO HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 153 SOLACE NUTRITION: MAJOR PRODUCT OFFERINGS
  • TABLE 154 THE KRAFT HEINZ COMPANY: MAJOR PRODUCT OFFERINGS
  • TABLE 155 GLOBAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 156 GLOBAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 157 GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 ($ BILLION)
  • TABLE 158 GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2023-2029 (%)
  • TABLE 159 GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 ($ BILLION)
  • TABLE 160 GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT FORM 2023-2029 (%)
  • TABLE 161 GLOBAL CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 ($ BILLION)
  • TABLE 162 GLOBAL CLINICAL NUTRITION MARKET BY AGE GROUP 2023-2029 (%)
  • TABLE 163 GLOBAL CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 ($ BILLION)
  • TABLE 164 GLOBAL CLINICAL NUTRITION MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 165 GLOBAL CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 ($ BILLION)
  • TABLE 166 GLOBAL CLINICAL NUTRITION MARKET BY DISTRIBUTION CHANNELS 2023-2029 (%)
  • TABLE 167 GLOBAL CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 ($ BILLION)
  • TABLE 168 GLOBAL CLINICAL NUTRITION MARKET BY END-USERS 2023-2029 (%)
  • TABLE 169 GLOBAL ORAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 170 GLOBAL ORAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 171 GLOBAL ENTERAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 172 GLOBAL ENTERAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 173 GLOBAL PARENTERAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 174 GLOBAL PARENTERAL CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 175 GLOBAL POWDER FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 176 GLOBAL POWDER FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 177 GLOBAL LIQUID FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 178 GLOBAL LIQUID FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 179 GLOBAL SEMI-SOLD FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 180 GLOBAL SEMI-SOLD FORM CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 181 GLOBAL CHILDREN & TEENAGERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 182 GLOBAL CHILDREN & TEENAGERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 183 GLOBAL INFANT & TODDLERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 184 GLOBAL INFANTS & TODDLERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 185 GLOBAL ADULTS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 186 GLOBAL ADULTS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 187 GLOBAL GERIATRIC CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 188 GLOBAL GERIATRIC CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 189 GLOBAL MALNUTRITION CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 190 GLOBAL MALNUTRITION CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 191 GLOBAL METABOLIC DISORDERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 192 GLOBAL METABOLIC DISORDERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 193 GLOBAL GASTROINTESTINAL DISORDERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 194 GLOBAL GASTROINTESTINAL DISORDERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 195 GLOBAL CANCER CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 196 GLOBAL CANCER CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 197 GLOBAL OTHER APPLICATIONS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 198 GLOBAL OTHER APPLICATIONS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 199 GLOBAL INSTITUTIONAL SALES CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 200 GLOBAL INSTITUTIONAL SALES CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 201 GLOBAL PHARMACIES & DRUG STORES DISORDERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 202 GLOBAL PHARMACIES & DRUG STORES DISORDERS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 203 GLOBAL SUPERMARKETS & HYPERMARKETS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 204 GLOBAL SUPERMARKETS & HYPERMARKETS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 205 GLOBAL ONLINE SALES CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 206 GLOBAL ONLINE SALES CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 207 GLOBAL SPECIALTY STORES CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 208 GLOBAL SPECIALTY STORES CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 209 GLOBAL OTHER DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 210 GLOBAL OTHER DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 211 GLOBAL HOSPITALS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 212 GLOBAL HOSPITALS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 213 GLOBAL INDIVIDUALS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 214 GLOBAL INDIVIDUALS CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 215 GLOBAL HOMECARE CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 216 GLOBAL HOMECARE CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 217 GLOBAL LTC CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 ($ BILLION)
  • TABLE 218 GLOBAL LTC CLINICAL NUTRITION MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 219 CURRENCY CONVERSION (2017-2023)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!